FrancophonIA/DGT-Translation_Memory huggingface dataset:
English: COMMISSION DECISION of 18 July 1994 amending the Decision of 18 December 1992 concerning the placing on the market of a GMO containing product, the vaccine Nobi-Porvac Aujeszky live (gI , tk), pursuant to Article 13 of Council Directive 90/220/EEC
Portuguese: DECISÃO DA COMISSÃO de 18 de Julho de 1994 que altera a Decisão de 18 de Dezembro de 1992 relativa à colocação no mercado de um produto que contém um OGM, a vacina Nobi-Porvac Aujeszky live (gl , tk), nos termos do artigo 13º da Directiva 90/220/CEE do Conselho
Czech: ROZHODNUTÍ KOMISE ze dne 18. července 1994, kterým se mění rozhodnutí ze dne 18. prosince 1992 o uvedení na trh produktu obsahujícího geneticky modifikovaný organismus, živou očkovací látku Nobi-Porvac-Aujeszky (gI, tk), podle článku 13 směrnice Rady 90/220/EHS
Slovak: ROZHODNUTIE KOMISIE z 18. júla 1994, ktorým sa na základe článku 13 smernice Rady 90/220/EHS mení a dopĺňa rozhodnutie z 18. decembra 1992 týkajúce sa uvedenia vakcíny Nobi-Porvac Aujeszky live (gI, tk) obsahujúcej geneticky modifikované organizmy na trh
Polish: DECYZJA KOMISJI z dnia 18 lipca 1994 r. zmieniająca decyzję z dnia 18 grudnia 1992 r. dotyczącą wprowadzenia do obrotu produktu zawierającego GMO, żywej szczepionki Nobi-Porvac Aujeszky (gl, tk), na mocy art. 13 dyrektywy Rady 90/220/EWG
Hungarian: A Bizottság határozata (1994. július 18.) a 90/220/EGK tanácsi irányelv 13. cikke szerint egy GMO-t tartalmazó termék – a Nobi-Porvac Aujeszky élővakcina (gI-, tk-) – forgalomba hozataláról szóló 1992. december 18-i határozat módosításáról
Slovenian: Odločba Komisije z dne 18. julija 1994 o spremembi Odločbe z dne 18. decembra 1992 o dajanju v promet izdelka, ki vsebuje GSO, cepiva Nobi-Porvac Aujeszky živ (gI, tk), v skladu s členom 13 Direktive Sveta 90/220/EGS
Bulgarian: РЕШЕНИЕ НА КОМИСИЯТА от 18 юли 1994 година за изменение на Решението от 18 декември 1992 г. относно пускането на пазара на продукт, съдържащ генетично модифицирани организми (ГМО), живата ваксина Nobi-Porvac Aujeszky (gI-, tk-), съгласно член 13 от Директива 90/220/ЕИО на Съвета
Estonian: KOMISJONI OTSUS, 18. juuli 1994, millega muudetakse 18. detsembri 1992. otsust, mis käsitleb GMOd sisaldava toote, Nobi-Porvac Aujeszky haiguse vastane elusvaktsiini (gI-, tk-) turuleviimist vastavalt nõukogu direktiivile 90/220/EMÜ
Latvian: Komisijas Lēmums (1994. gada 18. jūlijs), ar ko groza 1992. gada 18. decembra Lēmumu par ĢMO saturoša produkta, dzīvas Nobi-Porvac Aujeszky vakcīnas (gI–, tk–) laišanu tirgū saskaņā ar Padomes Direktīvas 90/220/EEK 13. pantu
Lithuanian: Komisijos Sprendimas 1994 m. liepos 18 d. iš dalies keičiantis 1992 m. gruodžio 18 d. Sprendimą dėl GMO turinčio produkto — gyvybingo Nobi-Porvac Aujeszky (gI–, tk–) vakcinos — pateikimo į rinką pagal Tarybos direktyvos 90/220/EEB 13 straipsnį
Maltese: ID-DEĊIŻJONI TAL-KUMMISSJONI tat-18 ta' Lulju 1994 li temenda d-deċiżjoni tat-18 ta' Diċembru 1992 dwar it-tpoġġija fis-suq ta' prodott li fih GMO, it-tilqima Nobi-Porvac Aujeszky ħaj (gI-, tk-), skond l-Artikolu 13 tad-Direttiva tal-Kunsill 90/220/KEE
English: Whereas, the Commission has forwarded the dossier to the Competent Authorities of all Member States; whereas the Competent Authority of another Member State has raised an objection to the said dossier;
Italian: considerando che la Commissione ha trasmesso il fascicolo alle autorità competenti di tutti gli Stati membri e che l'autorità competente di un altro Stato membro ha sollevato un'obiezione al fascicolo in questione;
English: Whereas, according to this procedure, and in particular with regard to Article 13, a Commission Decision was taken on 18 December 1992 (1) enabling the Competent Authority of the Federal Republic of Germany to give consent for the placing on the market of the following product, notified by Vemie Veterinaer Chemie GmbH
Slovak: keďže podľa tohoto postupu, a najmä podľa článku 13, bolo dňa 18. decembra 1992[1] prijaté rozhodnutie Komisie umožňujúce vydať príslušným orgánom Spolkovej republiky Nemecko povolenie, aby sa na trh uviedol nasledujúci produkt, notifikovaný spoločnosťou Vemie Veterinär Chemie GmbH
English: (Ref. C/D/92/I-1):
Slovak: (zn. C/D/92/I-1):
English: Nobi-Porvac Aujeszky live (gI , tk)
Polish: żywa szczepionka Nobi-Porvac Aujeszky (gI, tk)
English: (with Diluvac forte)
Polish: (razem z Diluvac forte)
English: Nobi-Porvac Aujeszky live (gI , tk) (with Diluvac forte) Pseudorabies virus (strain Begonia) (for intra-muscular application only);
Hungarian: Nobi-Porvac Aujeszky élő (gI-, tk-) (Diluvac forte-val készített) pszeudoveszettség-vírus (Begonia törzs) (kizárólag intramuszkuláris felhasználásra);
Lithuanian: gyvybingą Nobi-Porvac Aujeszky (gI–, tk–) (su Diluvac forte) pseudopasiutligės virusą (Begonia štamas) (tik intramuskuliniam naudojimui);
English: Whereas, according to this procedure, and in particular with regard to Article 13, a Commission Decision was taken on 18 December 1992 (1) enabling the Competent Authority of the Federal Republic of Germany to give consent for the placing on the market of the following product, notified by Vemie Veterinaer Chemie GmbH (Ref. C/D/92/I-1): Nobi-Porvac Aujeszky live (gI , tk) (with Diluvac forte) Pseudorabies virus (strain Begonia)
Latvian: tā kā saskaņā ar šo procedūru un jo īpaši ar 13. pantu 1992. gada 18. decembrī tika pieņemts Komisijas lēmums [1], ar ko Vācijas Federatīvās Republikas kompetentā iestāde piekrita laist tirgū šādu produktu, ko izziņojis Vemie Veterinär Chemie GmbH (Ref. C/D/92/I-1): dzīva Nobi-Porvac Aujeszky (gI–, tk–) (ar Diluvac forte), pseidotrakumsērgas vīruss (celms Begonia), (tikai intramuskulārai lietošanai);
English: (for intra-muscular application only); Whereas, subsequent to that Decision, a further notification has been received by the Competent Authority of the Federal Republic of Germany from the same notifier, requesting that consent be given for extending the use to intra-dermal application as well;
Latvian: tā kā pēc šī lēmuma Vācijas Federatīvās Republikas kompetentā iestāde no tā paša paziņotāja ir saņēmusi turpmāku paziņojumu ar lūgumu dot piekrišanu paplašināt lietošanu arī intradermāli;
English: A favourable decision is hereby taken, according to which, the product Nobi-Porvac Aujeszky live, containing a genetically modified pseudorabies virus (strain Begonia) (gI, tk) in a preparation with Diluvac Forte, modified by Vemie Veterinaer Chemie GmbH (Ref. C/D/92/I-1) and for which consent has been given by a Commission Decision of 18 December 1992 for the placing on the market as a live vaccine for Aujeszky disease to be administered by intra-muscular application only, shall now also be given consent for intra-dermal application as well.
Latvian: Ar šo ir pieņemts labvēlīgs lēmums, ar ko attiecībā uz Nobi-Porvac Aujeszky dzīvās vakcīnas produktu, kas satur ģenētiski modificētu pseidotrakumsērgas vīrusu (celms Begonia) (gI–, tk–) preparātā ar Diluvac Forte, ko modificējis Vemie Veterinaer Chemie GmbH (Ref. C/D/92/I-1) un par ko Komisijas 1992. gada 18. decembra lēmumā ir dota piekrišana laist tirgū kā dzīvu vakcīnu pret Aujeszky slimību, lietojot tikai intramuskulāri, tagad ir dota piekrišana to lietot arī intradermāli.
English: C (92) 3215 final.
Italian: C (92) 3215 def.
Slovak: C (92) 3215, konečné.
Polish: C (92) 3215 ostateczna.
Bulgarian: С (92) 3215 окончателен.
Estonian: C (92) 3215 lõplik
Latvian: C (92) 3215 galīgā versija.